Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Not yet recruiting × Cryosurgery × Clear all

Phase

Phase NA 4 Phase 2 3 Phase 1/2 1

Status

Completed 16 Withdrawn 1 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Bevacizumab 14 Injections 10 Drug Therapy 10 Gemcitabine 8 tislelizumab 6 irinotecan sucrosofate 6 Paclitaxel 6 Cyclophosphamide 6 pembrolizumab 5 Temozolomide 5 Oxaliplatin 5 Leucovorin 5 Fluorouracil 5 Carboplatin 5 Biopsy 5 130-nm albumin-bound paclitaxel 5 venetoclax 4 toripalimab 4 fludarabine 4 Magnetic Resonance Spectroscopy 4 HMPL-013 4 Etoposide 4 Dexamethasone 4 Cisplatin 4 trametinib 3 sintilimab 3 lenvatinib 3 enzalutamide 3 durvalumab 3 Specimen Handling 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05806385 2025-09-09

LOGIC

Texas Tech University Health Sciences Center

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡